Drosophila melanogaster Gene Microarray Service
InquiryObesity is a multifaceted metabolic disorder characterized by excessive lipid accumulation and systemic physiological imbalances. While human clinical studies are complex and costly, D. melanogaster has emerged as a premier model organism for deciphering the genetic underpinnings of metabolic syndrome. Sharing approximately 75% of human disease-related genes, the fruit fly possesses analogous organs for lipid storage (fat body), insulin production (IPC cells), and nutrient absorption (midgut).
D. melanogaster Gene Microarray Service for Obesity Research
Protheragen provides a specialized D. melanogaster gene microarray service designed to map global transcriptional changes in response to high-fat diets, caloric restriction, and pharmacological interventions. By leveraging high-density oligonucleotide arrays, we enable researchers to identify differentially expressed genes (DEGs) that drive adiposity and metabolic dysfunction. Our platform transforms raw biological samples into actionable genomic insights, facilitating the discovery of novel therapeutic targets and the validation of phytochemical efficacy in a cost-effective, high-throughput preclinical environment.
Core Technologies
Our microarray platform integrates advanced genomic tools specifically optimized for the Drosophila genome. We utilize high-resolution probe sets that cover the entire annotated transcriptome, including non-coding RNAs that play critical roles in metabolic regulation.
- Customized Metabolic Arrays
Specifically designed probe sets for genes involved in insulin signaling (InR, AKT), lipogenesis (FASN, ACC), and fatty acid oxidation.
- Precision RNA Stabilization
Proprietary buffer systems ensure the integrity of volatile metabolic transcripts during the transition from fly tissue to cDNA.
- Bioinformatic Integration
Advanced algorithms for gene ontology (GO) enrichment and KEGG pathway analysis, focused on lipid metabolism and endocrine signaling pathways.
- Signal Amplification Modules
Enhanced detection sensitivity for low-abundance transcription factors involved in energy homeostasis, such as dFOXO and dSREBP.
Service Scope
Our service covers a broad spectrum of genomic inquiries related to metabolic health:
- Transcriptome Profiling
Whole-genome expression analysis under various nutritional stresses.
- Nutrigenomics Screening
Evaluating the impact of phytochemicals and functional foods on gene expression patterns.
- Gene Knockdown/Overexpression Validation
Confirming the downstream transcriptional effects of CRISPR or RNAi-mediated metabolic perturbations.
- Developmental Metabolic Mapping
Tracking gene expression changes from larval stages through metamorphosis to understand the ontogeny of obesity.
- Microbiome-Host Interactions
Analyzing how gut microbiota alterations influence systemic metabolic gene expression.
View Our Full Suite of Drosophila Services
Workflow
Protheragen employs a streamlined, rigorous five-stage process to ensure the highest data fidelity for your obesity research projects.
Fields of Application
These customized metabolic arrays enable a broad spectrum of research opportunities across multiple scientific domains, supporting advanced investigations into lipid regulation, hormonal signaling, organismal aging, metabolic toxicology, and nutrient-driven metabolic modulation.
- Pharmaceutical Target Discovery: Identifying novel enzymes and receptors that regulate lipid storage.
- Endocrinology: Studying the evolutionarily conserved insulin/IGF-1 signaling (IIS) pathway.
- Aging and Longevity: Investigating the link between metabolic rate, fat accumulation, and lifespan.
- Toxicology: Assessing the metabolic disruptive effects of environmental endocrine disruptors.
- Nutritional Science: Screening the bioactivity of natural compounds in preventing fat accumulation.
Advantages
Protheragen stands at the forefront of Drosophila genomics, offering unparalleled precision for preclinical metabolic studies.
Unmatched Sensitivity
Our platform is engineered to detect subtle fold-changes in metabolic regulators that are frequently lost in the "noise" of standard sequencing. By optimizing signal-to-noise ratios, we ensure that low-abundance transcripts—often the most critical metabolic switches—are captured with absolute clarity.
Cost-Efficiency
While RNA-Seq is often the default, microarray technology remains the high-throughput gold standard for large-scale screening. We offer a superior ROI for targeted metabolic studies, allowing for more biological replicates and experimental conditions within the same budget, ensuring your data is statistically robust rather than just "high-tech."
Data Reliability
Our method is based on strict quality standards. We demonstrate a high correlation between Drosophila microarray profiles and mammalian metabolic markers, providing you with a reliable bridge for translational research and confidence in your "fly-to-human" predictions.
Rapid Turnaround
In the race to market, every week counts. Our highly optimized internal workflows allow us to transition from sample reception to a comprehensive bioinformatic report in record time—significantly outpacing industry averages without compromising data integrity.
Expert Interpretation
We do not just deliver spreadsheets; we deliver answers. Our PhD-level specialists provide expert interpretation, mapping Drosophila gene shifts directly to human orthologs and clinical disease pathways. We transform raw data into a narrative that informs your next move in the lab.
Inquire Today to Accelerate Your Obesity Research Pipeline.
Customer Review
High-Resolution Pathway Discovery – Uncovering Hidden Metabolic Drivers
"Working with Protheragen revolutionized our approach to screening phytochemicals. Their microarray service identified a specific set of cytochrome P450 genes upregulated by our lead compound, which we had previously overlooked. The data was so clean and well-interpreted that it directly informed our next phase of mammalian testing. We view Protheragen as an essential extension of our R&D department."
Dr. S. A., Nutraceutical Research Institute
Accelerated Screening for Nutraceutical Innovation – Precision Tissue-Specific Insights for Clearer Data Interpretation
"The precision of the micro-dissection performed by the Protheragen team is impressive. We were struggling with background noise in our whole-body samples, but their fat-body-specific array analysis provided the clarity we needed to map the insulin signaling defects in our model. We are already planning our next three projects with their genomic team."
Dr. C. B., University Metabolic Health Lab
Frequently Asked Questions
-
Why choose microarrays over RNA-Seq for obesity research?
Microarrays offer exceptional reproducibility and cost-effectiveness for high-volume screening of known metabolic pathways, making them ideal for initial target identification.
-
Can you analyze specific tissues like the fat body?
Yes, we specialize in micro-dissection of the Drosophila fat body to provide tissue-specific insights into lipid metabolism.
-
What is the minimum sample size required?
We typically require a pool of 20-30 flies per replicate, but our sensitive amplification protocols can work with less if needed.
-
How do you handle the high lipid content in obese fly samples?
We utilize specialized lysis buffers designed to efficiently separate lipids from nucleic acids, ensuring high-purity RNA.
-
Are the results applicable to human obesity?
Absolutely. Most lipid metabolism pathways are highly conserved, and we provide ortholog mapping to human genes in our final report.
-
Can this service support drug screening?
Yes, it is an excellent tool for assessing the transcriptomic "fingerprint" of candidate anti-obesity compounds.
-
Do you provide bioinformatic support?
Every project includes a full bioinformatic analysis, including pathway enrichment and functional annotation.
-
What fly strains are compatible?
Our arrays are compatible with all standard D. melanogaster laboratory strains and transgenic lines.
-
How are the results delivered?
You receive a comprehensive digital report including raw data files, normalized datasets, and publication-ready figures.
Contact Us
Protheragen is committed to providing the high-end genomic tools necessary to combat the global obesity crisis. Our D. melanogaster gene microarray service offers the precision, speed, and expertise required to transform your metabolic research into breakthrough discoveries.
Contact Protheragen for More Information and to Discuss Your Project
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.